223 related articles for article (PubMed ID: 8483037)
1. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats.
Gerhart TN; Roux RD; Hanff PA; Horowitz GL; Renshaw AA; Hayes WC
J Orthop Res; 1993 Mar; 11(2):250-5. PubMed ID: 8483037
[TBL] [Abstract][Full Text] [Related]
2. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
Zelken J; Wanich T; Gardner M; Griffith M; Bostrom M
Clin Orthop Relat Res; 2007 Sep; 462():190-4. PubMed ID: 17514008
[TBL] [Abstract][Full Text] [Related]
3. Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system.
Laurencin CT; Gerhart T; Witschger P; Satcher R; Domb A; Rosenberg AE; Hanff P; Edsberg L; Hayes W; Langer R
J Orthop Res; 1993 Mar; 11(2):256-62. PubMed ID: 8483038
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic-eluting hydrophilized PMMA bone cement with prolonged bactericidal effect for the treatment of osteomyelitis.
Oh EJ; Oh SH; Lee IS; Kwon OS; Lee JH
J Biomater Appl; 2016 May; 30(10):1534-44. PubMed ID: 26847915
[TBL] [Abstract][Full Text] [Related]
5. Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin.
Brin YS; Golenser J; Mizrahi B; Maoz G; Domb AJ; Peddada S; Tuvia S; Nyska A; Nyska M
J Control Release; 2008 Oct; 131(2):121-7. PubMed ID: 18692531
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model.
Boyle KK; Sosa B; Osagie L; Turajane K; Bostrom MPG; Yang X
PLoS One; 2019; 14(9):e0222034. PubMed ID: 31536540
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Joosten U; Joist A; Gosheger G; Liljenqvist U; Brandt B; von Eiff C
Biomaterials; 2005 Sep; 26(25):5251-8. PubMed ID: 15792552
[TBL] [Abstract][Full Text] [Related]
8. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
Faber C; Stallmann HP; Lyaruu DM; Joosten U; von Eiff C; van Nieuw Amerongen A; Wuisman PI
Antimicrob Agents Chemother; 2005 Jun; 49(6):2438-44. PubMed ID: 15917544
[TBL] [Abstract][Full Text] [Related]
9. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
[TBL] [Abstract][Full Text] [Related]
11. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
Shirtliff ME; Calhoun JH; Mader JT
Clin Orthop Relat Res; 2002 Aug; (401):239-47. PubMed ID: 12151901
[TBL] [Abstract][Full Text] [Related]
12. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats.
Lucke M; Schmidmaier G; Sadoni S; Wildemann B; Schiller R; Haas NP; Raschke M
Bone; 2003 May; 32(5):521-31. PubMed ID: 12753868
[TBL] [Abstract][Full Text] [Related]
13. A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.
Mistry S; Roy S; Maitra NJ; Kundu B; Chanda A; Datta S; Joy M
J Control Release; 2016 Oct; 239():169-81. PubMed ID: 27582374
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of teicoplanin- and calcium sulfate-loaded PMMA bone cement in preventing implant-related osteomyelitis in rats.
Tuzuner T; Sencan I; Ozdemir D; Alper M; Duman S; Yavuz T; Yildirim M
J Chemother; 2006 Dec; 18(6):628-33. PubMed ID: 17267341
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic release from an experimental biodegradable bone cement.
Gerhart TN; Roux RD; Horowitz G; Miller RL; Hanff P; Hayes WC
J Orthop Res; 1988; 6(4):585-92. PubMed ID: 3379512
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental osteomyelitis by methicillin resistant Staphylococcus aureus with bone cement system releasing grepafloxacin.
Efstathopoulos N; Giamarellos-Bourboulis E; Kanellakopoulou K; Lazarettos I; Giannoudis P; Frangia K; Magnissalis E; Papadaki M; Nikolaou VS
Injury; 2008 Dec; 39(12):1384-90. PubMed ID: 18656187
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats.
Itokazu M; Ohno T; Tanemori T; Wada E; Kato N; Watanabe K
J Med Microbiol; 1997 Sep; 46(9):779-83. PubMed ID: 9291890
[TBL] [Abstract][Full Text] [Related]
18. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats.
Mendel V; Simanowski HJ; Scholz HC; Heymann H
Arch Orthop Trauma Surg; 2005 Jul; 125(6):363-8. PubMed ID: 15864679
[TBL] [Abstract][Full Text] [Related]
19. [Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits].
Lambotte JC; Thomazeau H; Cathelineau G; Lancien G; Minet J; Langlais F
Chirurgie; 1998 Dec; 123(6):572-9. PubMed ID: 9922597
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
